NCT01764165View on ClinicalTrials.gov

Pathogenesis and Outcomes of Sleep Disordered Breathing in Chronic Obstructive Pulmonary Disease (COPD)

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
COPD
Interventions
OTHER

Oxygen

oxygen at a rate of 2 L/min will be delivered through a small nasal cannula throughout sleep.

OTHER

High flow of room air

Warm and humidified air at rates of 20 L/min will be delivered through a small nasal cannula throughout sleep

Trial Locations (1)

21224

Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Johns Hopkins University

OTHER

NCT01764165 - Pathogenesis and Outcomes of Sleep Disordered Breathing in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter